Decades in the making.
Moleculeon Science arrives with the work already done. The science was published before the company had a name. The manufacturing was certified before there was anything to announce. The products are on shelves in several markets, and some of them have been through controlled human studies.
What is new is the name over the door. Vigentis and the four divisions of Beyond grew up separately. They are now one group, under one quality system, stepping forward together.
Two Nobel sciences
The discovery that specific proteins instruct cells to grow took the 1986 Nobel Prize in Medicine. The machinery that lets cells package and ship those signals in vesicles took the 2013 prize. We manufacture both, and co-formulate them as one system.
Pharmaceutical standards
ISO 22716 GMP certified equipment and process control, with a Certificate of Analysis on every batch and documentation prepared for regulatory review.
Already in supply
Our regenerative actives reach clinics and formulators through Halyra, and are formulated into finished products already on sale internationally.
What comes next
Raw is trading today. The rest of Beyond opens in sequence.
Alongside them sits the part of the group that took the longest to build and matters most: a therapeutics program aimed at the biology of aging itself.
Contact
Moleculeon Science Company Ltd.
正陀生技股份有限公司
5F-1, No. 176, Sec. 1, Zhongxiao E. Rd.
Taipei City, Taiwan